80 JAZZ shares were withheld to cover taxes or exercise cost (CEO) | OQRO Insider tradesWhy it stands out
Routine share withholding; mechanical by default.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 5, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 10, 2025
CEOTax withholding
Context
- Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
- Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001607737-25-000004
Added to OQROOct 6, 2026, 7:59 PM UTC Data qualityVerified: identifiers matched exactly IssuerJazz Pharmaceuticals plc Reporting personRenee D Gala Officer titlePresident & CEO TableNon-derivative (Table I) Transaction dateDec 5, 2025 Acquired / disposedDisposed (D) Shares owned after107,860 Footnotes from the filing
- The Reporting Person acquired 71 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.
Around the same time
Not classified as an open-market trade.
Jazz Pharmaceuticals's SVP, Technical Operations sold $379K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.
Officer sold ~$27K of Jazz Pharmaceuticals
Automatic sale